TrialBMC pediatrics2017

Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial.

Luca Filippi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.